Doctor Ji Jing has been appointed as Executive Director ABBISKO-B(02256)
Hoyo-B (02256) announced that Dr. Chen Zhui has resigned as an executive director of the company, effective March 3, 2025...
ABBISKO-B (02256) announced that Dr. Zui Chen has resigned as an executive director of the company, effective from March 3, 2025. Dr. Yuhong Ping, our current Chief Scientific Officer and executive director, will continue to lead our research and development work. Dr. Yaochang Xu, Dr. Yuhong Ping, and Dr. Zui Chen have entered into a termination agreement to terminate the joint action agreement, effective from March 3, 2025. Dr. Jing Ji has been appointed as an executive director of the company, effective from March 3, 2025.
Related Articles
Zhongtai: Policy and technology driving the dual wheels of the photovoltaic industry towards high-quality development.
Equinix, Inc. (EQIX.US) Q3 Performance Meeting: Plans to double capacity by 2029, ecosystem continues to expand in multiple industries such as AI.
ServiceNow held a Q3 conference call, where they reported that their Assist growth rate is exceeding expectations and they plan to surpass $500 million by the end of the year.
Zhongtai: Policy and technology driving the dual wheels of the photovoltaic industry towards high-quality development.
Equinix, Inc. (EQIX.US) Q3 Performance Meeting: Plans to double capacity by 2029, ecosystem continues to expand in multiple industries such as AI.
ServiceNow held a Q3 conference call, where they reported that their Assist growth rate is exceeding expectations and they plan to surpass $500 million by the end of the year.
RECOMMEND
First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025
Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025
Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025
